Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone plus oral isotretinoin versus triamcinolone alone for post-septorhinoplasty nasal swelling in thick-skinned adults
IRCT20251115067999N1Phase 3Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triamcinolone and isotretinoin in rhinitis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Nasal edema severity and Edema persistence duration. Started May 2026; status: recruiting.
02
Drugs
triamcinoloneisotretinoin
03
Conditions
rhinitis
Beyond the preview
Go deeper on IRCT20251115067999N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251115067999N1.